MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Sagimet Biosciences Inc. Series A Common Stock

SGMT

#3054
Sagimet Biosciences Inc. Series A Common Stock
5.71
-1.04%
Sector:
Base:
Profit Currency:
Daily Range
5.71
5.71
Year Range
1.73
11.41
Daily Change
-1.04%
Monthly Change
-6.55%
6 month change
-26.04%
Year Change
+58.17%
Previous Close
5.77
Open
5.71
Bid
Ask
Low
5.71
High
5.71
Volume
21
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. SGMT
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20232024 TTM

News

Investing Investing
SGMT
2026.02.02
Sagimet stock rises after positive Phase 3 safety data for acne drug
Investing Investing
SGMT
2026.02.02
Ascletis reports positive long-term safety data for acne drug denifanstat
Seeking Alpha Seeking Alpha
SGMT TEVA MDGL
2025.12.19
Sagimet: Positive Denifanstat Combination PK Data Could Lead To Untapped Market (SGMT)
Investing Investing
SGMT
2025.12.18
Sagimet reports positive Phase 1 results for MASH combination therapy
Seeking Alpha Seeking Alpha
INCY ABVX MDGL ALKS IMTX
2025.12.16
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Investing Investing
SGMT
2025.11.21
Sagimet Biosciences executive chairman sells $290k in shares
Investing Investing
SGMT
2025.11.14
Sagimet Biosciences stock price target raised to $35 by Citizens
Investing Investing
SGMT
2025.10.24
Denifanstat meets all endpoints in phase 3 acne trial in China
Benzinga Benzinga
PYPL FSLR SGMT V
2025.10.22
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - First Solar (NASDAQ:FSLR), Klaviyo (NYSE:KVYO)
Investing Investing
MDGL SGMT
2025.10.21
Sagimet Biosciences stock initiated with Buy rating at Clear Street
Zacks Zacks
SGMT
2025.10.15
All You Need to Know About Sagimet Biosciences Inc. (SGMT) Rating Upgrade to Strong Buy
Seeking Alpha Seeking Alpha
SGMT
2025.10.07
Denifanstat Advances: Sagimet Builds Momentum Toward 2026 Readouts (NASDAQ:SGMT)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd